Lab Institute Masthead
Advertising | Contact Us
G2 Intelligence © 2014 Kennedy Information, LLC
A Bloomberg BNA Business
Phone: 800-531-1026 or +1-603-357-8101
All Rights Reserved.
More from G2 Intelligence

Speakers

Speakers Lab Institute 2014 is pleased to welcome these distinguished speakers. These individuals have demonstrated excellence in the industry and we thank them for sharing their knowledge with the Lab Institute community.
!!hns:g2_include_speakerheader!!
Richard Adams Richard Adams Administrative Director, Summa Health System/ LabCarePLUS
With experience comprising over thirty years in hospital administration, health insurance/managed care organizations and physician management services, Richard currently serves as the Administrative Director of LabCarePLUS, a regional laboratory outreach service within the Summa Health System. He received his master's degree in Health Care Administration from Virginia Commonwealth University and is the 2014 President-Elect of the American College of Health Care Executives of Northern Ohio.
!!hns:g2_include_speakerheader!!
Julie Scott Allen Julie Scott Allen Government Relations Director and Senior VP, District Policy Group, Drinker Biddle & Reath; and Washington representative for the American Association of Bioanalysts & National independent Laboratory Association
Julie Scott Allen is a government relations director with the firm’s Lobbying & Advocacy team and senior vice president with the District Policy Group. For more than 15 years, Julie’s focus has been government relations, including advocating at the federal and state level and promoting legislative, regulatory and business agendas for nonprofit and for profit clients and national organizations. Prior to joining the firm, Julie served as vice president and managing director at Thompson Advisory Group, where she represented clients before the executive and legislative branches in the areas of health care, education, document security, information technology, homeland security, law enforcement and the federal budget process. Previously, Julie served as manager of legislative and regulatory policy at the American Dental Association where she worked to address federal programs and health policies that affect the practice of dentistry. Julie joined the ADA after working as senior staff for the American College of Obstetricians and Gynecologists. Julie has authored and coauthored numerous reports, congressional testimony and other health policy materials concerning medical and dental issues. She has also organized and presented at national and state-focused meetings on such issues as access to health services, Medicaid reform and women’s health. Julie earned her bachelor’s degree, cum laude, from Marymount University.
!!hns:g2_include_speakerheader!!
Michael Armstrong Michael Armstrong, CLS, ASCP, SC, DLM Chief Operating Officer, Pacific Rim Pathology and Analytic Pathology Medical Groups
Michael is the Chief Operating Officer for Pacific Rim Pathology and Analytic Pathology Medical Groups in San Diego, California. He is an MBA, CLS, ASCP, SC, DLM and a certified Six Sigma Green Belt. With over 30 years of experience working from bench to boardroom he has a proven track record in business development, operations and strategic planning to not only strengthen business infrastructures, but to also increase revenue and growth. His is skilled in all aspects of regulatory, compliance, and quality improvement in both the Clinical Laboratory and Anatomic Pathology areas within inpatient and outpatient settings.
!!hns:g2_include_speakerheader!!
Janet Cohen Janet Cohen Director of IT, Genesis Biotechnology Group
Janet Cohen has over 30 years of experience focusing mainly in the healthcare, pharmaceutical and biotechnology industries. She currently serves as Director of Information Technology at Genesis Biotechnology Group (GBG), a consortium of ten vertically integrated entities including Medical Diagnostic Laboratory, L.L.C. (MDL) Based in Hamilton, NJ, GBG facilitate the overall market implementation of delivery of basis science products such as diagnostic assays and drug discovery. Janet joined MDL in 2004 as a consultant to the IT department and was appointed IT director in 2004. Founded in 1997, MDL serves primarily as a reference labs for PCL based testing top physicians, laboratories and hospitals worldwide. Janet has overall responsibility for the strategic plan, design and implementation of the enterprise wide technology infrastructure including all custom software development supporting GBG business and laboratory functions.
She is also responsible for establishing and maintaining all EMR connectivity and for supporting the MDL billing software and workflow.
Janet has a baccalaureate degree in chemistry from Stem College, Yeshiva University in New York.
!!hns:g2_include_speakerheader!!
James Crawford, M.D., Ph.D. James Crawford Executive Director and Senior Vice President for Laboratory Services, North Shore-LIJ Health System; Chair, Department of Pathology, Hofstra North Shore-LIJ School of Medicine
James M. Crawford, M.D., Ph.D., is Professor and Chair, Department of Pathology and Laboratory Medicine, Hofstra North Shore-LIJ School of Medicine, and Executive Director and Senior Vice President of Laboratory Services, North Shore-LIJ Health System. He received his M.D. and Ph.D. degrees from Duke University School of Medicine (1983), his post-graduate training in Anatomic Pathology and Gastrointestinal Pathology at Brigham and Women's Hospital (1983-1987), followed by a Fellowship in Hepatic Pathology at the Royal Free Hospital in London (1989). He has served on faculty and as a staff pathologist at Harvard Medical School and Brigham and Women's Hospital (1988-1996), and the Yale University School of Medicine (1997-1999). From 1999-2008, he was Professor and Chair, Department of Pathology, Immunology and Laboratory Medicine at the University of Florida College of Medicine in Gainesville, FL. He has held his current position at North Shore-LIJ since January 2009. Dr. Crawford is a leading proponent of the role of pathology and laboratory medicine in patient-centered care, and in supporting the coordinated care requirements of accountable care, including the use of pathology informatics. He is past-president of the Association of Pathology Chairs (APC), has served as Chair of the Council of Academic Societies of the Association of American Medical Colleges (AAMC), and on the AAMC Board of Directors.
!!hns:g2_include_speakerheader!!
A. Neil Crowson, M.D., FCAP, FRCPC A. Neil Crowson Chief of Staff, St. John Health System; President, Pathology Laboratory Associates and Vice President, Regional Medical Laboratory
Dr. Crowson is currently President of Pathology Laboratory Associates, Vice President of Regional Medical Laboratory and Chief of Medical Staff at St. John Medical Center in Tulsa, OK.
Dr. Crowson joined Pathology Laboratory Associates and Regional Medical Laboratory at St. John Medical Center in April of 1999, coming from Winnipeg, Canada. He did his premed at Queens University in Kingston, Ontario and attended medical school at the University of Manitoba, graduating in 1980. He did his postgraduate training at the University of Toronto in Anatomic Pathology and Hematopathology. He spent fourteen years in Winnipeg doing combined AP and CP and directing the laboratory department at the Misericordia General Hospital and Central Medical Laboratories. Dr. Crowson is a Clinical Professor of Dermatology, Pathology and Surgery at the University of Oklahoma Medical School, where he is Director of Dermatopathology. He has over 320 publications including an award-winning book on melanoma, now in press as a second edition, Textbook of Dermatopathology (McGraw Hill, 2010) which he co-edits with Raymond Barnhill, Cynthia Magro and Michael Piepkorn, Biopsy Interpretation of the Skin (Lippincott, 2010) and The Cutaneous Lymphoid Proliferations (Wiley, 2007). He maintains active research interests in the molecular biology of skin cancer and the inflammatory dermatoses, and directs the 5-day ASCP education course entitled Dermatopathology : Contemporary Diagnostic Criteria and Strategies, on an annual basis.
!!hns:g2_include_speakerheader!!
Ben Davis, M.D. Ben Davis Chairman & CEO, PathGroup
Ben Davis, M.D. Chairman, President, and Chief Executive Officer of PathGroup, Inc. in Nashville, Tennessee, since its founding in 1996. Dr. Davis has also served as President and Chief Executive Officer of Associated Pathologists during this period. Prior to joining Associated Pathologists in 1986, he was an Assistant Professor in the Department of Pathology, Vanderbilt University Medical Center and School of Medicine after completing a Residency in Anatomic and Clinical Pathology at Vanderbilt in 1981. Dr. Davis received his Undergraduate Degree with a B.A. in Molecular Biology at Vanderbilt University in 1973 and his M.D. at the University of Arkansas School of Medicine in 1977. Other notable experiences include serving as Chairman of the HCA Healthcare Network Institutional Review Board (1989-2008) and as Group Leader of the Experimental Pathology Unit, Ludwig Institute for Cancer Research, Molecular Biology Branch, Bern Switzerland (1981-1983).
!!hns:g2_include_speakerheader!!
Lee Dilworth Lee Dilworth Chief Legal & Administrative Officer, American Pathology Partners
Mr. Dilworth has over 20 years of legal experience as a corporate and healthcare transactional attorney. Prior to joining APP, he was Senior Vice President and General Counsel of Attentus Healthcare Company, an operator of rural acute care hospitals, where he was responsible company-wide for legal, development, compliance, information security, and risk management matters. Previously, he was a Member, Managing Partner and Chair of the Corporate Practice at Harwell Howard Hyne Gabbert & Manner, P.C. (H3GM), a Nashville, Tennessee-based law firm specializing in advising private and public healthcare clients on various strategic transactions.
During his 18 year tenure at H3GM, Mr. Dilworth was involved in numerous public and private company M&A transactions, including approximately 75 hospital acquisitions and divestitures, multiple physician joint ventures, and representation of specialty physician groups throughout the southeastern U.S. Mr. Dilworth was a founder of Health & Productivity Corporation of America, a provider of integrated health and health-related productivity and disease management services.
Mr. Dilworth is listed in editions of The Best Lawyers in America and America’s Leading Business Lawyers. Mr. Dilworth holds a BA in business administration from Furman University, a JD from the University of Georgia School of Law, and a LL.M in taxation from New York University School of Law.
!!hns:g2_include_speakerheader!!
Brenda Eriksen, M.D. Brenda Eriksen Medical Director of System Laboratories, Community Healthcare System
Dr. Brenda Eriksen received her Bachelor of Science in Physics from the University of Illinois in 1982. She completed medical school at Rush University in Chicago in 1986. Her post graduate training in Pathology was completed at Northwestern Memorial Hospital in Chicago in 1990. She worked as a board certified staff pathologist at St. Margaret Hospital in Hammond, Indiana since 1990 and as medical director of the laboratories there from 1997-2002. Since 2003 until the present, Dr. Eriksen is the medical director of the laboratories of the Community Healthcare System. She and the laboratory administrative leadership began a manual program of laboratory test utilization in 2005 which continues to expand as new tools are acquired including CPOM and the EMR.
!!hns:g2_include_speakerheader!!
Keith Fontenot Keith Fontenot Managing Director of Government Relations and Public Policy, Hooper, Lundy & Bookman, PC
Mr. Fontenot is the Managing Director of the Government Relations & Public Policy department of Hooper, Lundy & Bookman, PC. Mr. Fontenot brings to the firm a wealth of experience in health policy at the highest levels of government, in both the Executive and Legislative branches. Most recently, as the top health care budget official at OMB he was heavily involved in the development and implementation of the Affordable Care Act. In his four years in that role, he advised the most senior levels of the White House, the top leadership of key federal health agencies, and members of Congress, on budget, legislative, and regulatory issues in major health programs.
In addition to his four plus years as Associate Director for Health at OMB, Mr. Fontenot served as Deputy Assistant Director for Health and Human Resources at the Congressional Budget Office (CBO), and as Chief of the Health Financing Branch at OMB. In these positions Mr. Fontenot was closely involved in virtually every aspect of health policy, including: the creation of new payment systems in post acute care, major reforms to other payment systems in Medicare, negotiation of Medicaid waivers, and development and implementation of the Medicare prescription drug program. He oversaw cost estimates and related analysis for health, education and income security programs at CBO, and was deeply involved in helping the agency prepare for health reform legislation, including CBO’s development of options such as Accountable Care Organizations.
Mr. Fontenot is also a Visiting Scholar at the Brookings Institution, where he works with former CMS Administrator Mark McClellan on Brookings’ ongoing efforts in health reform. Mr. Fontenot began his federal career as a budget examiner at OMB for Social Security and other retirement programs in 1982. He holds a M.A. in public policy from Duke University, and a B.A. from the Old Dominion University.
!!hns:g2_include_speakerheader!!
Katherine Frey, M.D. Keith Fontenot Director of Patient Blood Utilization Management, Fairview Southdale Hospital
Dr. Kathrine Frey is an Anatomic and Clinical Pathologist with subspecialty certification in Transfusion Medicine. She practices general pathology at a 400 bed community hospital in Minneapolis, MN where she is also director of Patient Blood Management (PBM).
PBM is an emerging medical specialty that engages interdisciplinary care givers to manage blood loss, blood use and anemia treatment for inpatients and outpatients. The pathologist is a natural “go to” as the leader for this work.
PBM initiatives began at Dr. Frey’s hospital in 2009. Blood use decreased rapidly with 20% less use within 6 months, over 35% less use sustained for the last 6 years and blood use appropriateness 97% or better.
Savings have been upward of 30 MM$. The benefit to patients, their caregivers and the hospital in terms of best care and avoidance of adverse effects of anemia and unnecessary transfusions is priceless and can be leveraged to attract new patients, insurers and more.
!!hns:g2_include_speakerheader!!
Peter Gosselin Senior Healthcare Analyst, Bloomberg Government
Peter Gosselin is a Senior Healthcare Analyst with Bloomberg Government. He was a special economic adviser for health reform at the Department of Health and Human Services and chief speechwriter to Treasury Secretary Timothy Geithner. Gosselin spent 35 years at newspapers, most recently as chief economics correspondent for the Los Angeles Times. He has a bachelor’s degree from Brown University and an MBA in economics from Columbia Business School
!!hns:g2_include_speakerheader!!
Marc D. Grodman, M.D. Marc Grodman Chairman, President, and CEO
Dr. Marc D. Grodman, M.D. has been the Chairman, Chief Executive Officer and President of Bio-Reference Laboratories Inc. since December 1981 and serves its Managing Director. Dr. Grodman founded Bio-Reference Laboratories in December 1981. He serves as Secretary of The Actors Fund. He is an Assistant Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons and Assistant Attending Physician at Presbyterian Hospital, New York City. From 1982 to 1984, he served as Medical Consultant to the Metal Trades Department of the AFL-CIO. He serves as the Chairman of CareEvolve.com, Inc. He has been a Director of BioReference Laboratories Inc. since December 1981. He serves as a Trustee of The Actors Fund. Since January 2005, he has been a member of the Board of Directors of the American Clinical Laboratory Association. From 1980 to 1983, he attended the Kennedy School of Government at Harvard University and was a Primary Care Clinical Fellow at Massachusetts General Hospital. Dr. Grodman received a B.A. degree from the University of Pennsylvania in 1973 and an M.D. degree from Columbia University College of Physicians and Surgeons in 1977.
!!hns:g2_include_speakerheader!!
Peter G. Gudaitis Lee Dilworth President, Aculabs Inc.
Peter G. Gudaitis is president of New Brunswick, NJ-based Aculabs, Inc., the largest provider of laboratory services to the long-term care community on the East Coast. Founded in 1972, the family owned lab company has served LTC facilities for more than 40 years and primarily does business in New Jersey, Pennsylvania, Delaware and Maryland. Aculabs has been a member of the American Clinical Laboratory Association since 2008 with Paul currently serving on the ACLA Board of Directors.
!!hns:g2_include_speakerheader!!
Eric Hammelman Eric Hammelman Vice President, Avalere Health
Eric Hammelman is Vice President of Avalere where he, provides data-driven analysis of the impact of various legislative and policy changes on the healthcare industry, with a specific focus on reimbursement for providers. Prior to joining Avalere, Eric was an Associate Analyst with J.P.Morgan, where he analyzed healthcare service companies and provided investment advice to institutional investors. He built financial and industry models for hospitals, nursing homes, dialysis, hospice, ambulatory surgery centers, clinical labs, inpatient rehab, long-term acute care, and physician groups. He also analyzed payment policies for each of these areas, including Medicare, Medicaid, and private payers. Eric has a Bachelors of Music Performance from the University of Illinois at Urbana-Champaign. He also earned an M.B.A. from the Marshall School of Business (University of Southern California), as well as a Masters of Music Performance from the Mannes College of Music in New York, N.Y. Eric has passed all three levels of the CFA exam.
!!hns:g2_include_speakerheader!!
Eleanor Herriman, M.D., MBA Eleanor Herriman Managing Director, Advisory Services, G2 Intelligence
L. Eleanor J. Herriman, M.D., MBA, is a pathologist executive with 15+ years experience in the medical technology industry. She has worked across sectors with both small ventures and corporations. Her market experience spans the clinical laboratory, in vitro diagnostics, e-health, biotech, and strategy consulting for Bain & Company. Other key accomplishments include growing a venture with a CLIA lab and FDA PMA approved computer-assisted cytology instrument from start-up to publicly traded company (IPO raised $100 million).
She is the leader of G2 Intelligence’s advisory services, which provides strategic consulting and custom market research and assessments for a range of clients, including pathology groups, clinical labs, health systems, hospitals, medical centers, diagnostic technology companies, and investors.
She is the author of three G2 reports: Health Care Market Reforms: Implications and Prescriptions for Laboratories; How to Build a Molecular Testing Laboratory: Key Strategic & Operational Considerations; and Creating a Value-Driven Laboratory: Opportunities in the New Marketplace.
She earned her M.D. at Baylor College of Medicine, completed pathology residency at University of California San Francisco, and received an MBA from Harvard Business School with highest honors (Baker Scholar).
!!hns:g2_include_speakerheader!!
Patric Hooper Esq. Patric Hooper Founding Partner, Hooper Lundy Bookman
Mr. Hooper received his A.B. degree in economics from the University of California at Los Angeles in 1970. He received his J.D. from the University of San Diego School of Law in 1973.
In 1973, Mr. Hooper began his legal career with the California Department of Justice, where, as a Deputy Attorney General, he represented various state agencies in civil litigation involving health, education, and welfare matters.
Since 1976, he has specialized in litigation against the federal and state governments involving health care matters. He has been involved in hundreds of administrative and judicial proceedings throughout the country as the lead trial and appellate attorney. His cases include some of the most important and complex Medicare, Medicaid and CHAMPUS (TriCare) cases in the health care field.
In 1987, Mr. Hooper, together with Bob Lundy and Lloyd Bookman, formed the national health care law firm of Hooper, Lundy & Bookman, P.C. in Los Angeles. As a founding member of Hooper, Lundy & Bookman, Mr. Hooper has continued to represent health care providers in health care disputes with federal and state governments throughout the country.
In addition to his involvement in resolving disputes, Mr. Hooper also regularly advises nonprofit and for-profit health care organizations regarding reimbursement, certification and licensure issues associated with business transactions and combinations. He continuously advises health care providers of Medicare, Medicaid and CHAMPUS fraud and abuse issues and on state anti-rebate and referral issues. Mr. Hooper is a frequent lecturer before national health care organizations on issues pertaining to the health care field and has published numerous articles on a variety of health care matters.
Mr. Hooper is a former general counsel to the National Association of Psychiatric Treatment Centers for Children, and is a member of the American Health Lawyers Association, the Healthcare Financial Management Association, the California Society of Healthcare Attorneys, and the California Clinical Laboratory Association. He was also the first chair of the Fraud and Abuse Interest Group of the ABA Health Law Section.
In May 2013, Mr. Hooper received the prestigious UCLA Longevity Center ICON Award for "Visionary Leadership in Healthcare Law." He is an annual recipient of "Best Healthcare Lawyer" awards issued by state and national publications such as Chambers USA and the Best Lawyers In America.
!!hns:g2_include_speakerheader!!
Annette Iacono Annette Iacono Vice President, Brookside Clinical Laboratory, Inc.
Annette Iacono is vice president of Brookside Clinical Laboratory, Inc., a family-owned business established in Brookhaven, Pennsylvania, in 1966 by her father John Iacono.
Ms. Iacono attended American University (AU) in Washington, D.C., on a full Division I basketball scholarship. She received a BSBA from the AU Kogod School of Business. After graduating, she joined the Oliver T. Carr Company in Washington, D.C., serving as director of operations.
Ms. Iacono joined Brookside in September 1990 as vice president.
A member of the American Association of Bioanalysts (AAB) since 1991, Ms. Iacono has served as AAB president, vice president, and board member. She helped to create the Executive Officers Section of AAB, which developed into the National Independent Laboratory Association (NILA), a very influential resource on Capitol Hill. Her leadership as NILA vice chair and secretary has helped the clinical laboratory industry win many battles.
!!hns:g2_include_speakerheader!!
Elaine Jeter Elaine Jeter, M.D. Medical Director, Palmetto, GBA
Elaine K. Jeter is the Palmetto GBA J11 Medical Director. She received a Bachelor of Science degree from the State University of New York at Geneseo in biology/marine science and an MS in biology from the University of South Carolina. Dr. Jeter received her MD from Medical University of South Carolina (MUSC), and completed a five-year residency in anatomical and clinical pathology. She has AP/CP boards from the American College of Pathology, and specialty boards in blood-banking/transfusion medicine. Dr. Jeter was on the faculty at MUSC in pathology and in the private practice of pathology for many years prior to joining Palmetto GBA.
!!hns:g2_include_speakerheader!!
Paul Keckley, Ph.D. Paul Keckley Managing Director, Navigant Healthcare and Navigant Center for Healthcare Research and Policy Analysis
Paul H. Keckley, Ph.D., is a health economist and leading expert on U.S health reform and its impact. He recently joined Navigant Healthcare as Managing Director and leader of the Navigant Center for Healthcare Research and Policy Analysis. Previously he served as Executive Director for the Deloitte Center for Health Solutions ("the Center") in Washington DC directing the Center’s non-partisan studies that are prominently featured in Congressional testimony and industry publications.
Dr. Keckley has authored three books, more than 150 articles, and the Monday Memo on Health Reform circulated in 20,000 healthcare companies and legislative bodies. He has testified before Congress and facilitated White House Office of Health Reform working sessions as the Affordable Care Act was being negotiated and focused on ways the private sector could improve health care safety and quality while reducing costs by $2 trillion. He is a frequent speaker and regular commentator in media coverage of health reform and its impact in key sectors of the health system. He also teaches in the School of Health Systems Administration at Georgetown University as an adjunct professor focused on disruptive innovation in health care.
Dr. Keckley currently serves on the boards of the Ohio State University Medical Center, Healthcare Financial Management Leadership Council, and Lipscomb University College of Pharmacy. He is member of the Health Executive Network and advisor to the Bipartisan Policy Center in Washington DC. Prior to joining Deloitte, he served in leadership roles at Vanderbilt University leading the Medical Center’s international joint ventures, the Vanderbilt Center for Integrative Health, the healthcare MBA program launch, and the Vanderbilt Center for Evidence-based Medicine (VCEBM). Before joining Vanderbilt, he was Chairman of Interdent, a California dental practice management company; Chief Executive Officer of EBM Solutions, a venture-capital backed start-up founded by Vanderbilt, Duke, Emory and Washington University-St. Louis; President of PhyCor Management Corporation, the IPA Management subsidiary of PhyCor Inc., and Managing Partner of The Keckley Group, a health industry research firm.
He completed his B.A. at Lipscomb University, MA and PhD degrees from Ohio State University, and a fellowship in economic policy at Oxford University. He resides in Nashville, Tennessee and enjoys golf, jogging, and the search for great coffee.
!!hns:g2_include_speakerheader!!
Tara Kochis Tara Kochis President, Slone Partners
Tara Kochis is President of Slone Partners. She brings over a decade of solid healthcare experience to the company, which she joined in 2004, having been consistently ranked as one of the top-producing sales representatives with industry leaders such as VERSYSS, American Medical Laboratories, and Quest Diagnostics. Her highly successful, award-winning sales career covered a variety of healthcare segments, including information technology, medical records, and most importantly, the diagnostic and laboratory testing industries. Prior to healthcare, Ms. Kochis honed her recruitment skills in the banking and finance sector, filling a wide variety of financial positions.
Her executive recruitment skills coupled with her extensive healthcare background help her quickly and accurately assess candidates for the benefit of Slone Partners’ clients. Ms. Kochis graduated cum laude, receiving a Bachelor of Science, with a concentration in Human Resources Management, from Boston College. She is an active member of AACC, ACHE, and CLMA.
!!hns:g2_include_speakerheader!!
Paul Koeppel Paul Koeppel Laboratory Business Operations Manager, Intermountain Healthcare Central Entities
Mr. Keoppel has worked in and with clinical laboratories for over 40 years. He has worked in hospitals, consulting, commercial laboratories, a core laboratory and corporate administration. His current position is the Laboratory Business Operations Manager for Intermountain Healthcare. Paul holds a master’s degree in business administration and a bachelor degree in Clinical Laboratory Science from Weber State University. He is certified in healthcare compliance with the Health Care Compliance Association (HCCA).
!!hns:g2_include_speakerheader!!
Gail Marcus Gail Marcus President and CEO, Calloway Laboratories, Inc.
Gail Marcus is a senior health care executive with more than 25 years' experience managing and growing domestic and international businesses. Since October 2012 she has served as President and CEO of Calloway Laboratories, Inc., one of the nation's fastest growing toxicology labs.
Ms. Marcus previously served as chief administrative officer for Hartford Healthcare and before that, she was a Partner and Healthcare Segment Leader for Tatum LLC eastern region and an advisor and consultant to health care services organizations, including hospital systems, managed care organizations and diagnostic companies.
From 2006-2008, she was President and CEO of Caris Diagnostics, a privately held laboratory company. Under her leadership, Caris became one of the nation’s leading aggregators of anatomic and molecular diagnostic services.
Prior to her tenure with Caris Diagnostics, Ms. Marcus served as Chief Operating Officer for United HealthCare European Operations, building a complete health care consulting and services business. Before joining United Health Care, she served as Senior Vice President and Chief Product and Revenue Officer at Advance PCS Pharmacy Benefits Management, where she also led the post-merger integration with Caremark.
Ms. Marcus spent more than 20 years at CIGNA HealthCare in various financial, product, strategy and marketing roles, including Assistant Treasurer; Vice President and Controller; Senior Vice President, Product Development; and Senior Vice President, Chief Operating Officer, International Operations. While based in the UK, Ms. Marcus was assigned as a turn-around specialist for the troubled overseas life and health businesses.
Marcus holds an MBA in finance from The Wharton School and an MS in information sciences from the University of Pennsylvania. She received a BA in mathematics and Spanish from Wesleyan University. She is an adjunct professor at the University of Connecticut business school, teaching health care courses in the MBA program. She sits on the boards of Susan G. Komen for the Cure, Connecticut affiliate, where she is chair of the Grants Committee; Bako Pathology; XpertDoc; and the Commission for Case Management.
!!hns:g2_include_speakerheader!!
Alan Mertz Alan Mertz President, American Clinical Laboratory Association
Since becoming President of ACLA in 2003, Alan Mertz has overseen a more than tripling of ACLA’s membership, greater visibility of ACLA in Congress and the Administration, expansion of ACLA membership services, meetings and programs, and a series of key advocacy successes.
ACLA took the lead in opposing a provision in the 2003 Medicare Modernization Act that would have added coinsurance for laboratory services in Medicare. From 2004-2008, ACLA led an advocacy campaign to stop the Medicare Laboratory Competitive Bidding Demonstration Project which resulted in, first, a federal court injunction against the project, followed by the statutory repeal of the project in June 2008. During the consideration of health care reform legislation in 2009-2010, ACLA took the lead in opposing proposals for a new federal tax on laboratory services as well as another attempt to impose laboratory coinsurance. In the same legislation, ACLA supported expanding coverage for the uninsured, a fair application of the “Productivity Adjustment,” provisions promoting prevention and wellness, extension of the so-called “TC Grandfather Clause,” and the “Date of Service” Demonstration.
In 2007, ACLA launched the “Results for Life” educational campaign aimed at promoting the value of laboratory services. In 2009, ACLA started its growing Associate Member program for non-laboratory health care companies and organizations as a means of broadening education and communication with the laboratory industry’s health partners.
Prior to taking the reins at ACLA, Mertz was Executive Vice President and Acting President of the Healthcare Leadership Council (HLC), and from 1980 to 1998 served in three senior staff positions in the House and Senate. He was selected as a John C. Stennis Congressional Fellow in 1996, taught as an adjunct professor at George Washington University from 1997-1999, and is a frequent lecturer at American University in Washington, DC. He holds a Masters Degree in American Politics from American University and a BA in Government from Monmouth College.
!!hns:g2_include_speakerheader!!
Stephanie Murg Stephanie Murg Managing Director, G2 Intelligence
Stephanie Murg is the Managing Director of G2 Intelligence, responsible for the live events business line as well as thought leadership roles in G2’s market research and advisory services.
Prior to joining G2, she was a research associate at JPMorganChase, Harvard Business School, and the National Bureau of Economic Research. She also has several years of laboratory experience in molecular and behavioral neuroscience research, with a focus on neurodegenerative disease.
Murg co-authored peer-reviewed publications in the Journal of Neuroscience, Human Gene Therapy, and Neurobiology of Learning and Memory, and co-wrote a chapter in the most recent edition of the textbook Neuropsychology of Memory. She received a bachelor’s degree in neurobiology from Harvard.
!!hns:g2_include_speakerheader!!
Kathy Murphy Kathleen Murphy, Ph.D. Chief Executive Officer, Chi Solutions, Inc.
KATHLEEN A. MURPHY, Ph.D., CEO and owner of Chi Solutions, has over 25 years of experience in diagnostic services management and consulting. As Chi’s senior executive, Kathy oversees complex engagements involving strategic options development, operations optimization, consolidation, and outreach program implementation. A noted speaker and author, she also directs the annual performance and publication of Chi’s widely regarded and referenced Comprehensive National Laboratory Outreach Survey. Kathy’s education and training is primarily as a scientist with executive education at Dartmouth College and Harvard Business School. In her spare time, Kathy enjoys traveling, gardening, volunteering, and spending time with her golden retriever, Flora.
!!hns:g2_include_speakerheader!!
Barry Portugal Barry Portugal President, Health Care Development Services, Inc.
Barry Portugal is President of Health Care Development Services, Inc., a strategic business planning management consulting firm. Mr. Portugal has undergraduate and graduate degrees in business administration from the University of Illinois and the University of Pennsylvania, respectively. He also attended Northwestern Law School.
Prior to forming Health Care Development Services, Inc., in 1981, Mr. Portugal held several senior management positions with firms in the health care industry. During the 13 years Mr. Portugal spent on the corporate side of the industry, he served as sales manager, marketing manager, and corporate officer in charge of marketing for Technicon Instruments Corporation; Telemed Corporation, a division of Becton-Dickinson; and Damon Corporation.
Mr. Portugal consults with hospitals, large multi-specialty group practices, clinical laboratories, and pathology groups. His special area of interest is strategic planning and business development of health care providers. In this role, Mr. Portugal has designed business plans which have successfully achieved goals desired by client organizations.
Mr. Portugal is a member of the American Hospital Association Society for Hospital Planning, Clinical Laboratory Management Association, the American Association for Clinical Chemistry, the American Pathology Foundation, and the Medical Group Management Association. Additionally, Mr. Portugal has had written articles published in Clinical Laboratory Management Review, Pathologist, and the Medical Group Management Association Journal. He has been a featured speaker at meetings of the American Hospital Association, Health Care Financial Management Association, American College of Healthcare Executives, Clinical Laboratory Management Association, and the American Pathology Foundation, focusing on hospital laboratory strategic planning and business development.
!!hns:g2_include_speakerheader!!
George Poste, D.V.M., D.Sc., Ph.D. George Poste Chief Scientist, Complex Adaptive Systems Initiative; Regents' Professor; and Del E. Webb Chair in Health Innovation, Arizona State University
George Poste is Chief Scientist, Complex Adaptive Systems Initiative (CASI), Regents’ Professor and Del E. Webb Chair in Health Innovation at Arizona State University. He assumed this post in February 2009. This program links expertise across the university in research on synthetic biology, ubiquitous sensing and healthcare informatics for personalized medicine.
He founded the Biodesign Institute at ASU and served as Director for 2003 to 2009. In creating this Institute, Dr. Poste designed and built 400,000 sq. ft. of new facilities, achieved cumulative research funding of $300 million and recruited over 60 faculty, including three members of the National Academies of Science and Engineering.
He serves on the Board of Directors of Monsanto (since 2003), Exelixis (since 2004), Caris Life Sciences (since 2005), and the Scientific Advisory Board of Synthetic Genomics (since 2009). From 1992 to 1999 he was Chief Science and Technology Officer and President, R&D of SmithKline Beecham (SB). During his tenure at SB he was associated with the successful registration of 31 drug, vaccine and diagnostic products. In 2004 he was named as ‘R&D Scientist of the Year’ by R&D Magazine, in 2006 he received the Einstein award from the Global Business Leadership Council and in 2009 received the Scrip Lifetime Achievement award voted by the leadership of the global pharmaceutical industry.
He has published over 350 research papers and edited 14 books on pharmaceutical technologies and oncology. He has received honorary degrees in science, law and medicine for his research contributions and was honored in 1999 by HM Queen Elizabeth II as a Commander of the British Empire for his contributions to international healthcare and security.
He is a Fellow of the Royal Society, the Royal College of Pathologists and the UK Academy of Medicine, a Distinguished Fellow at the Hoover Institution, Stanford University and a member of the Council for Foreign Relations. He served as a member of the Defense Science Board from 2003 to 2009 and Health Board of the US Department of Defense (DoD) and is currently a member of the US Institute of Medicine Board on Global Health. He has served as a member of Advisory Committees for multiple U.S. Government Agencies in areas of defense, national security and healthcare.
!!hns:g2_include_speakerheader!!
Michael Reitermann CEO, Siemens Healthcare Diagnostics
Mr. Michael Reitermann serves as the Chief Executive Officer of Diagnostics Division of Siemens AG and Siemens Medical Solutions USA, Inc. Mr. Reitermann has been the Chief Executive Officer at Siemens Healthcare Diagnostics, Inc. since April 30, 2010. He served as the Chief Executive Officer of Siemens Healthcare Diagnostics Limited since April 30, 2010. Mr. Reitermann served as the Chief Executive Officer of U S at Siemens Healthcare since July 2009 and was responsible for sales, marketing, service and logistics across the Siemens Healthcare portfolio, including medical imaging equipment, healthcare information technology, and medical therapy. Mr. Reitermann served as President of Medical Solutions Nuclear Medicine Group of Siemens Medical Solutions USA, Inc. since July 2002. He served as the Chief Executive Officer of Siemens Molecular Imaging Business Unit and the former Nuclear Medicine Division at Siemens Medical Solutions. He was responsible for the establishment and implementation of the Molecular Imaging Division's business objectives around the world, as well as the Division's overall financial performance. He served as Vice President for Sales and Marketing of Angiography and X-ray Division (AX) at Siemens. In this position, he was responsible for the worldwide marketing and promotion of Siemens AX products, including the successful AXIOM product line. From 1996 to 1998, he was a Partner in Siemens Management Consulting, conducting consulting projects in the areas of benchmarking, strategy and productivity. Prior to 1996, he served as a Consultant, then a Senior Project Manager at the corporate strategies division of Siemens Corporate Planning and Development. He serves as a Member of Board of Governors at National Electrical Manufacturers Association. Mr. Reitermann was educated at Hans-Grueninger-Gymnasium in Markgroeningen, Germany. He received a graduate degree in Industrial Engineering from the University of Karlsruhe, Germany, and a Master's of Business Administration from the University of British Columbia, Canada.
!!hns:g2_include_speakerheader!!
John H. Scott John Scott Vice President, Advocacy and Policy, College of American Pathologists
John Scott began his Washington career in 1983 as a legislative assistant and press secretary for Rep. J. J. Jake Pickle of Texas, a member of the House Ways and Means Health Subcommittee. In 1987, he left the Hill to join the AMA as a congressional lobbyist where he worked for seven years, representing the AMA on critical issues such as the congressional enactment of the resource based relative value system for Medicare. In 1994, he joined the American College of Emergency Physicians as the director of ACEP's Washington Office. During his tenure at ACEP, Mr. Scott led ACEP’s successful legislative campaign to ensure coverage of emergency medical services by government and private health care plans. In 1998, John joined the College of American Pathologists where today he guides the CAP’s Division of Advocacy and Policy and the CAP Washington, DC Office.
!!hns:g2_include_speakerheader!!
Kimberly Scott Kimberly Scott Managing Editor, G2 Intelligence
As Managing Editor, Kimberly Scott oversees publication of G2 Intelligence’s newsletters: Laboratory Industry Report; G2 Compliance Report; National Intelligence Report; and Diagnostic Testing & Technology Report.
She has 25 years of experience covering health care issues, both on a national and local level. Since 2001, Kimberly has covered the clinical laboratory and diagnostic testing industries, with an emphasis on business strategy, operations, and compliance. Prior to that, she covered long-term care, mental health, and disability issues for business-to-business publications and wrote about federal health care for U.S. Medicine. Kimberly got her start in writing and reporting at the Daytona Beach News-Journal, where she worked first as a general assignment reporter, and later covered the medical beat.
She has a bachelor’s degree in journalism from Florida Southern College and a master’s degree in English from the University of Maryland.
!!hns:g2_include_speakerheader!!
Khosrow Shotorbani Khosrow Shotorbani CEO, TriCore Reference Laboratories
As CEO, Khosrow Shotorbani has overall responsibility for TriCore Reference Laboratories’ operations, growth and financial health. He also leads TriCore’s initiative to improve health outcomes and lower costs by using laboratory medicine to guide the utilization of other types of medical care.
Before joining TriCore in 2014, Mr. Shotorbani served as senior vice president and director of business innovations at Associated Regional and University Pathologists (ARUP). He joined ARUP in 1984 as a medical technologist and advanced to positions of progressive responsibility over his 30-year tenure there.
Mr. Shotorbani holds a master’s degree in business administration from the University of Phoenix and a bachelor’s degree in clinical laboratory science from Weber State University in Ogden, Utah. He is a member of the American College of Healthcare Executives and the Clinical Laboratory Management Association, among other industry-related organizations.
!!hns:g2_include_speakerheader!!
Ajit Singh Ajit Singh Partner, Artiman Ventures
Ajit focuses on early-stage Technology and Life Science investments. He is on the board for Aditazz, CardioDx, and Oncostem.
Ajit is also a Consulting Professor in the School of Medicine at Stanford University and serves on the Board of Directors of Max Healthcare based in New Delhi, India.
Prior to joining Artiman, Ajit was the President and CEO of BioImagene, a Digital Pathology company specializing in Cancer Diagnostics, based in Sunnyvale, CA. BioImagene was acquired by Roche in September 2010. Before BioImagene, Ajit spent nearly twenty years at Siemens in various roles, most recently as the Chief Executive Officer of the Digital Radiology and Medical Informatics business of Siemens Healthcare, based in Germany. From 2001 to 2006, Ajit was the President and CEO of the Oncology Care Systems Group of Siemens, with global headquarters in Concord, California. Between 1996 and 2001, Ajit held the positions of Group Vice President of Siemens e-Health, and Vice President of Siemens Health Services based in Princeton, NJ, where he led the company's Healthcare IT business and Consulting Practice. Before transitioning to these business responsibilities, Ajit spent several years in R&D and academia. From 1989 to 1995, he was at Siemens Corporate Research in Princeton, responsible for research in the areas of artificial intelligence, robotics, computer vision, and image analysis. During this time, he concurrently served on the faculty at Princeton University.
Ajit has a Ph.D. in Computer Science from Columbia University, a master's degree in Computer Engineering from Syracuse University and a bachelor's degree in Electrical Engineering from Banaras Hindu University, India. He has published two books and numerous refereed articles, and holds five patents.
!!hns:g2_include_speakerheader!!
Joe Skrisson Joseph Skrisson Chief Operating Officer, Dynacare Laboratories
Mr. Skrisson has over 30 years experience in Laboratory Medicine managing or directing Commercial or Hospital based Clinical Laboratories. He was one of the original founders of the JVHL ( i.e.“Joint Venture Hospital Laboratories”) network in Michigan. The JVHL is one of the oldest and most successful Laboratory networks in the nation. The JVHL enabled Hospital Outreach programs in Michigan to compete effectively against the National Laboratories. In addition, Mr. Skrisson, as the CEO of Piedmont Medical Laboratory, championed the Laboratory to become the first CAP ISO 15189 accredited Laboratory in the nation. Mr. Skrisson also has extensive experience in developing and implementing successful Laboratory Outreach Sales programs. Presently Mr. Skrisson holds the position of Chief Operating Officer for Dynacare Laboratories in Milwaukee. Dynacare is a joint venture between the Froedtert Health System and Laboratory Corporation of America and generates over $85 million in revenue annually with a staff of over 600 Laboratorians.
!!hns:g2_include_speakerheader!!
Leslie A. Sprick, MT (ASCP) Leslie Sprick Owner & CEO, Sprick Group
Leslie A. Sprick is Owner and CEO in the consulting practice of Sprick Group. The firm has been providing management consulting services for over a decade now, where her work has focused on Lean performance improvement, Lean facility planning, laboratory startups, consolidation studies of integrated delivery networks, operational reviews, technical workflow analysis, strategic business planning and interim management.
From 1998-2002, Ms. Sprick served as Senior Director of Performance Management for Premier, Inc. the largest Group Purchasing Organization in the healthcare industry. There she honed her consulting skills with some of the most prestigious healthcare systems in the US and developed specific programs that improved costs and efficiencies for Premier members. She helped drive increased sales volume by 100 percent in two years through Premier-sponsored contracts.
From 1990-1998, Ms. Sprick was Director of Sales and Marketing for Presbyterian Laboratory Services at Novant Health in Charlotte, North Carolina, where she was responsible for the start-up development of the laboratory’s outreach program that grew rapidly to $100M in eight years. She was a key member of the senior management team for 5 acute care hospital labs, 32 physician office labs, 3 regional STAT labs, a regional reference lab facility with a DHHS certified toxicology laboratory and a full-service Cytogenetics lab, GIFT and IVF laboratory, as well as 6500 skilled nursing beds in 52 facilities. She was an active member in the facility design and startup of four new clinical laboratories during her tenure, the largest a 54,000 square foot facility.
Ms. Sprick has a total of fourteen years experience as a management consultant. Her extensive performance improvement and laboratory start-up experience over the past 30 years has enabled her to formulate implementable solutions with a wide range of clients. She has a solid reputation for effective interaction with executives, administrators, physicians, technologists and other clinicians.
She is a national speaker and resource on Lean Six Sigma, hospital outreach programs and competitive issues with the laboratory industry. She earned her Bachelor’s in Health Sciences from the University of Missouri-Columbia and is a registered medical technologist. She is affiliated with the following professional organizations: the Clinical Laboratory Management Association, the American Society of Clinical Pathologists, the American College of Healthcare Executives and the Institute of Management Consultants.
Ms. Sprick is certified in Lean Manufacturing Techniques by the University of Michigan and is Green Belt Six Sigma certified.
!!hns:g2_include_speakerheader!!
Susan Stegall Susan Stegall Owner and CEO of M.S. Stegall and Associates, LLC
Ms. Stegall founded the management consulting practice of M. S. Stegall & Associates, LLC in January 2012. She is owner and CEO of the firm. Service lines include consultations involving Lean Six Sigma Process Improvement, Strategic and Operational Business Planning, and a new Coaching and Training venue. Ms. Stegall has twenty-two years of experience as a consultant and has provided viable and valuable business solutions to her world-class customer base.
Prior to forming this management consulting company, Ms. Stegall was Founder and Managing Partner of Sprick, Stegall & Associates, LLC, a well-respected management-consulting firm in the industry. Other positions held by Ms. Stegall include Vice President of Consulting Services at Chi Laboratory Systems, Inc., a company she was employed by for eleven years.
A seasoned laboratory consulting professional, Ms. Stegall has participated in and directed a wide variety of consulting engagements including market opportunity assessments, outreach business planning, strategic planning, facility planning including Lean design, Lean Six Sigma process improvement projects, and multi-facility laboratory consolidations / regional integrations.
Ms. Stegall has also held a number of laboratory management positions. In the various management roles, Ms. Stegall has had profit/loss responsibilities along with leadership and management oversight of the administrative, operational, and sales/marketing sectors of laboratory operations.
Ms. Stegall received her MBA and MHSA from Arizona State University and her BS in Medical Technology from Mount Union College in Alliance,Ohio. She is affiliated with the following professional organizations: Clinical Laboratory Management Association, American Society of Clinical Pathologists, American College of Healthcare Executives, American Society for Quality, and the Institute of Management Consultants, USA.
Ms. Stegall is certified in Lean Manufacturing Techniques through the University of Michigan. Ms. Stegall holds a certificate of training completion for her Green Belt and Black Belt from Six Sigma.us. In addition, she received her certification as a management consultant from the Institute of Management Consulting in December 2006—a distinction held by less than 1% of all practicing consultants in the USA.
Ms. Stegall publishes in her company’s Blog and in industry publications. Her most popular blog post to date is Lean and Six Sigma--Comparing and Contrasting the Process Steps. Susan is a lifelong learner, and is currently fixated and fascinated with the field of inbound marketing.
!!hns:g2_include_speakerheader!!
Douglas M. VanOort, Douglas M. VanOort Chairman of the Board of Directors and Chief Executive Officer, NeoGenomics Laboratories
Mr. VanOort has served as the Chairman of the Board of Directors and Chief Executive Officer of NeoGenomics since October 28, 2009. Prior to that he served as Chairman of the Board of Directors, Executive Chairman and Interim Chief Executive Officer from March 2009 to October 2009. He has been an Operating Partner with Summer Street Capital Partners since 2004 and a Founding Partner of Conundrum Capital Partners since 2000. From 1995 to 1999, he served as the Senior Vice President Operations for Quest Diagnostics, Incorporated. During this period Quest Diagnostics grew to approximately $1.5 billion in annual revenue through both organic growth and mergers and acquisitions. From 1982 to 1995, Mr. VanOort served in various positions at Corning Incorporated and ultimately held the position of Executive Vice President and CFO of Corning Life Sciences, Inc. In 1995, Corning spun off Corning Life Sciences, Inc. into two companies, Quest Diagnostics and Covance, Inc. Mr. VanOort serves as a member of the Board of Directors of several privately held companies. In addition, since 2000, Mr. VanOort is the Co-Owner of Vision Ace Hardware, LLC, a retail hardware chain. Mr. VanOort is a graduate of Bentley University.
!!hns:g2_include_speakerheader!!
Francisco Velazquez Francisco Velàzquez, M.D., S.M. President and CEO, PAML LLC & PAML Ventures
Francisco R. Velàzquez is the President and Chief Executive Officer for PAML, LLC and PAML Ventures. Prior to joining PAML, he was Managing Director for the Quest Diagnostics Nichols Institute, and Vice President for Focus Diagnostics. Dr. Velàzquez trained at the Mallory Institute of Pathology in Boston and the Boston University Medical Center, and is board-certified by the American Board of Pathology. Subsequent to his training, Dr. Velàzquez obtained a Masters in Health Care Management and Policy at the Harvard School of Public Health. In addition to being a nationally known Pathologist, Dr. Velàzquez has extensive experience as a physician executive specifically in system integration, regionalization, mergers and acquisitions, and financial turnarounds in Healthcare Systems, IDNs, and large academic medical centers.
He is former Professor and Chairman for the Department of Pathology and Anatomical Sciences at the State University of New York at Buffalo, and former Professor and Vice Chairman of the Department of Pathology at the University of Texas Southwestern Medical Center. Dr. Velàzquez has also held academic and clinical appointments at Boston Medical Center, Boston University Medical Center, Wayne State School of Medicine, the Detroit Medical Center, SUNY at Buffalo, and Kaleida Health.
A former Commissioner for Laboratory Accreditation for the College of American Pathologists, Dr. Velàzquez has held elected office in the CAP House of Delegates and has been a member of several CAP committees. He is currently serving on the Health Sciences & Services Authority (HSSA) Board of Directors in Spokane, Washington.
!!hns:g2_include_speakerheader!!
Diana Voorhees Diana Voorhees Principal/CEO, DV & Associates, Inc.
Having been Director of Sales and Marketing and Senior Consultant for a national coding and reimbursement firm for nearly five years, Diana Voorhees developed DV & Associates, a coding and reimbursement firm that provides consulting for physicians and facilities in all specialties. Ms. Voorhees has created a network of consultants with various health care backgrounds in order to provide quality, credible, and resourceful results for all consulting services. DV & Associates has been incorporated in excess of 14 years.
Ms. Voorhees initiated her career in laboratory medicine within the Division of Hematology, Department of Medicine, at the University of Utah. She has also worked with the Division of Hematology at The Ohio State University, the Clinical Chemistry Department at Holy Cross Hospital in Salt Lake City, and the Special Hematology and Hemostasis Laboratory at the University of Utah. She spent 14 years as an Associate Clinical Professor and administrative faculty of Medical Laboratory Sciences in the College of Pharmacy at the University of Utah. During her last year and a half in academia, she was recruited as Program Director to design, implement, and direct the program in cytotechnology in the Department of Pathology.
Upon leaving the university setting, Ms. Voorhees joined Coulter Corporation and provided technical support, customer training, and education, primarily in the western United States. She was recruited by a national coding and reimbursement consulting firm, Med-Index/Medicode, where she spent nearly five years developing and marketing the consulting services for hospitals and other facilities, performing consulting engagements, providing seminars for national associations, enhancing product development, and serving on various corporate committees.
Ms. Voorhees has authored/edited several articles for professional publications including Compliance Report, a monthly column in Advance Newsmagazine, MLO, Lab Medicine, ASCLS Newsletter, G2 Compliance Report, National Intelligence Report, and the Laboratory Compliance Insider newsletters. She has provided numerous seminars, teleconferences and audio conferences for various companies and organizations. Additionally, she completed a chapter on coding and reimbursement for a well-known textbook on administration.
Ms. Voorhees consults in pathology, radiology, oncology, and other diagnostic and therapeutic specialties. Her firm consults in all physician specialties and in all outpatient settings.
!!hns:g2_include_speakerheader!!
Ritu S. Ward, MAOM, MT (ASCP) Ritu Ward Assistant Vice President, Carolinas Laboratory Network
Ms. Ward joined Carolinas Health Care System in 2008 and serves as the AVP for Carolinas Laboratory Network. Ms. Ward has held multiple leadership positions in both hospitals and large reference laboratories. Her expertise includes developing and maintaining client relations, building business strategies and implementing regulatory compliance protocols and process improvements.
Ms. Ward enjoys teaching and is an advocate for focused patient outcome delivery systems.
Ms. Ward received her Bachelor in Medical Technology from George Washington University, a Bachelor in Biology from Howard University and a Masters in Organizational Management from University of Phoenix. She is a certified Medical Technologist and a Six Sigma Black Belt.
Ms. Ward is a member of various organizations ; American College of Healthcare Executives, Clinical Laboratory Management Association, National Association of Female Executives, American Society of Clinical Pathologists, and American Association of Blood Bank.
!!hns:g2_include_speakerheader!!
Wayne Wecksler, Ph.D. Wayne Wecksler General Manager, Pacific Diagnostic Laboratories
Wayne Wecksler, Ph.D. has been the General Manager at Pacific Diagnostic Laboratories since 2011. He received a doctorate in Biochemistry from the University of California, Riverside in 1978 and an MBA from UCLA in 1989.
Dr. Wecksler did his dissertation research on the mechanism of action of 1,25- dihydroxy-vitamin D. After a postdoctoral research fellowship at the French National Institutes of Health in Paris, he began his clinical laboratory career at Bio-Science Laboratories in Van Nuys, California. Bio-Science Laboratories eventually was acquired by SmithKline Beecham Clinical Laboratories and then Quest Diagnostics Laboratories.
During his twenty-four year career, Dr. Wecksler has held a number of positions in both R&D and Laboratory Operations, including two years as Operations Manager for Northern California for BioScience Laboratories and nine years as Technical Director and General Manager for SmithKline Beecham’s National Esoteric Testing Center in Van Nuys. During his last three years with SmithKline Beecham, he also had divisional responsibility for their Research and Technology Acquisition functions. Dr. Wecksler has published a number of original research papers in the areas of biochemistry, infectious diseases, and laboratory medicine.
!!hns:g2_include_speakerheader!!
Dennis Weissman Dennis Weissman Executive Editor, G2 Intelligence and Program Chair
One of the nation’s leading experts on the clinical diagnostic laboratory and pathology sectors, Dennis Weissman is President of Dennis Weissman & Associates, LLC and founder and Executive Editor of G2 Intelligence, an independent news and information company serving the health care industry.
Founded in 2004, Dennis Weissman & Associates, LLC provides public policy and strategic business intelligence and advice for the health care industry. Dennis is a well-known speaker before health care professional and industry trade groups nationwide. Prior to founding Washington G-2 Reports in 1979, he was Director of the Washington Office of the American Society for Medical Technology, and before that, worked as Special Assistant in the Office of the nation’s top health official in the U.S. Department of Health, Education, and Welfare.
He holds a bachelor’s degree in political science from the State University of New York at Buffalo and a master’s degree in higher education administration from Indiana University.
!!hns:g2_include_speakerheader!!
Lale White Lâle White Executive Chairman and CEO, XIFIN
Lâle White is a nationally recognized expert in the field of medical financial management and regulatory compliance, with over 25 years of experience in information systems development and medical billing. She lectures extensively on these topics and has consulted for major laboratories and laboratory associations throughout the U.S. She worked with HCFA and the U.S. Office of the Inspector General to develop the first OIG Model Compliance Program. Ms. White was previously Vice President - Finance of Laboratory Corporation of America (NYSE: LH), one of the largest clinical reference laboratories in the U.S., and its predecessor National Health Laboratories (NYSE: NHLI), where she led the software development of several accounts receivable, inventory, cost accounting and financial management systems for the laboratory industry. Ms. White has a B.A in finance and an M.B.A. from Florida International University.
!!hns:g2_include_speakerheader!!
Christopher Wixom Christopher Wixom, M.D. President, Pacific Rim Pathology and Analytic Pathology Medical Groups
Dr. Chris Wixom is currently the President of Pacific Rim Pathology and Analytic Pathology Medical Group in San Diego, California and a Pathologist and Medical Director at Sharp Memorial Hospital, a designated Planetree Patient-Centered and Magnet hospital. He specializes in Neuropathology and Blood Transfusion Services. He received his MD degree from the University of Utah School of Medicine, his residency from UCSD Medical Center, and fellowship in Neuropathology from the University of California San Diego, and is board certified in Anatomic and Clinical Pathology.
!!hns:g2_include_speakerheader!!
Jane Pine Wood Member, McDonald Hopkins
Jane Pine Wood, a member in the national Healthcare Practice Group at McDonald Hopkins law firm, has been elected by her peers to serve on the firm’s Board of Directors. Wood joined McDonald Hopkins in 1988 and is a nationally respected healthcare attorney who has given hundreds of speeches throughout the country to various healthcare groups. She counsels more than 450 pathology groups and numerous clinical labs.
Wood represents a variety of healthcare providers—physicians, clinical, anatomic and molecular laboratories, imaging centers, home health agencies, mental health providers, clinics, hospitals, and others. She advises her clients on a wide range of corporate, regulatory, reimbursement, contractual, and other issues. A prolific writer, Wood has written numerous articles for healthcare periodicals. She also is a frequent presenter at national and regional conferences and seminars
Wood received a J.D. degree in 1987 from Vanderbilt University School of Law and a B.A. degree from Texas A & M University, summa cum laude, in 1983. She is admitted to practice law in two states—Massachusetts and Ohio—and serves on the Cape Cod Hospital Ethics Committee.
!!hns:g2_include_speakerheader!!
Christopher Young, CHC Christopher Young President, Laboratory Management Support Services, and Editor, G2 Compliance Advisor
During nearly 40 years as a laboratory professional – and 20 years as a compliance expert – Mr. Young has had the opportunity to work in or with every kind of laboratory setting. He is certified in Health Care Compliance (CHC) by the Health Care Compliance Board of the Health Care Compliance Association. He is also an HEW-certified medical technologist, former chairperson of the Clinical Laboratory Management Association (CLMA) Health-Care Policy Committee (HCPC), and former member of the Medicare Billing Issues Committee (MBIC) for CLMA. Mr. Young is currently serving as the laboratory representative on the Carrier Advisory Committee for Arizona, and as an alternate representative for CLMA on the Pathology Coding Caucus. He has worked directly with government representatives in shaping laboratory legislation, and contributed articles to Vantage Point, Laboratory Industry Report, and other health-care publications. Mr. Young is currently working as an independent consultant specializing in regulatory matters and the development of compliance officers and programs for clinical laboratories. He speaks locally and nationally on health care compliance, regulatory issues, Medicare and Medicaid billing and other laboratory-specific topics.
!!hns:g2_include_symposiumspeakerheader!!
Eleanor Herriman, M.D., MBA Eleanor Herriman Managing Director, Advisory Services, G2 Intelligence
L. Eleanor J. Herriman, M.D., MBA, is a pathologist executive with 15+ years experience in the medical technology industry. She has worked across sectors with both small ventures and corporations. Her market experience spans the clinical laboratory, in vitro diagnostics, e-health, biotech, and strategy consulting for Bain & Company. Other key accomplishments include growing a venture with a CLIA lab and FDA PMA approved computer-assisted cytology instrument from start-up to publicly traded company (IPO raised $100 million).
She is the leader of G2 Intelligence’s advisory services, which provides strategic consulting and custom market research and assessments for a range of clients, including pathology groups, clinical labs, health systems, hospitals, medical centers, diagnostic technology companies, and investors.
She is the author of three G2 reports: Health Care Market Reforms: Implications and Prescriptions for Laboratories; How to Build a Molecular Testing Laboratory: Key Strategic & Operational Considerations; and Creating a Value-Driven Laboratory: Opportunities in the New Marketplace.
She earned her M.D. at Baylor College of Medicine, completed pathology residency at University of California San Francisco, and received an MBA from Harvard Business School with highest honors (Baker Scholar).
!!hns:g2_include_symposiumspeakerheader!!
Stephanie Murg Stephanie Murg Managing Director, G2 Intelligence
Stephanie Murg is the Managing Director of G2 Intelligence, responsible for the live events business line as well as thought leadership roles in G2’s market research and advisory services.
Prior to joining G2, she was a research associate at JPMorganChase, Harvard Business School, and the National Bureau of Economic Research. She also has several years of laboratory experience in molecular and behavioral neuroscience research, with a focus on neurodegenerative disease.
Murg co-authored peer-reviewed publications in the Journal of Neuroscience, Human Gene Therapy, and Neurobiology of Learning and Memory, and co-wrote a chapter in the most recent edition of the textbook Neuropsychology of Memory. She received a bachelor’s degree in neurobiology from Harvard.
!!hns:g2_include_symposiumspeakerheader!!
Richard Nicholson Richard Nicholson CEO, West Pacific Medical Laboratory
Richard Nicholson is the CEO and majority owner of West Pacific Medical Laboratory (WPML) in Southern California. He received his Bachelor of Science degree in Medical Technology from San Diego State University and his Master’s degree in Health Administration from University of Southern California.
Prior to his current position, Rick was the CEO and majority owner of Westcliff Medical Laboratories. He learned the lab business from the ground up, working as a courier, lab aide, administrator and later becoming the President/CEO.
After receiving numerous offers to sell between the years of 2000-2006, Rick chose a private equity group due to his desire to continue growth of the lab. He brings vast experience in running a lab in Southern California and going through the acquisition, transition and consolidation process of buying and selling laboratories.
After his non-compete ended, Rick reentered the lab marketplace. He purchased a majority interest in WPML in September 2010. WPML has grown from 250 specimens/day with revenue of just under $3 million/year to its current volume of 1,700 specimens/day (as of March) and expected revenue of $30 million for 2013.
!!hns:g2_include_symposiumspeakerheader!!
Michael Snyder Gregory Solak Principal, Clinical Lab Business Solutions LLC
Michael Snyder is the Principal for Clinical Lab Business Solutions (CLBS), a consulting firm that works with laboratories to deliver collaborative solutions to health plans and employer groups. Mike has 30 years of experience in the management of clinical laboratories. This knowledge, combined with the work Mr. Snyder did inside of a national health plan, has given him the tools to form CLBS and, Laboratory Management Services, a management services company that provides value to the health insurance and laboratory industries. Prior to forming CLBS, he was Vice President of Laboratory Networks for UnitedHealthcare (UHC). In that capacity, he directed the national strategy for laboratory services and participated in the development of UHC’s national provider network. Additionally, Mr. Snyder served as Director of Business Development for Mount Sinai Hospital’s Center for Clinical Laboratories, where he saw outreach revenues triple in the implementation of a business plan that focused efforts on billing solutions and demonstrated the value of the medical center’s laboratory to attending faculty. Finally, Mike also served as an executive with LabCorp (1980-2000), one of the largest commercial laboratories in the US. Mike is a frequent speaker on the subject of managed care contracting and the value of managed networks for laboratory services.
!!hns:g2_include_symposiumspeakerheader!!
Gregory Solak Gregory Solak Vice President, Laboratory Services, Kaleida Health
Gregory Solak, Vice President, Laboratory Services, Kaleida Health, has over 30 years of experience in laboratory and healthcare leadership. He has worked in and consulted for a number of large healthcare systems undertaking laboratory consolidations and outreach expansions. Cited as Top 50 in Health Care 2013 by Buffalo Business First, Greg is currently engaged in various and sweeping plans to further advance Kaleida Health Laboratories as the premier diagnostic resource to the physicians, patients, and payers of Western New York.
!!hns:g2_include_symposiumspeakerheader!!
Steve Stonecypher Steve Stonecypher Director of Managed Care, American Pathology Partners
A 15-year clinical laboratory professional, Mr. Stonecypher is currently the Director of Managed Care for American Pathology Partners, a full service pathology laboratory. Mr. Stonecypher has served as an executive in numerous capacities in healthcare, including finance, product development and payer relations, with special emphasis in sales, marketing, client services, diagnostics, disease management and biotech. His current responsibilities at American Pathology Partners include oversight of Managed Care relations, contract management and new market development.
Mr. Stonecypher is a graduate of Cal-State Long Beach with a B.S. in Health Care Administration, and earned an MBA from Houston Baptist University in Finance. He resides in Greensboro, North Carolina. View Mr. Stonecypher’s LinkedIn profile here.
!!hns:g2_include_symposiumspeakerheader!!
Scott Taillie Scott Taillie VP of Marketing & Business Development, Alere, Inc.
As Vice President of Marketing and Business Development for Alere, Inc., Scott manages the company’s national and corporate account groups, workplace solutions group, physician offices, and lab and hospital distribution partner teams. A highly experienced executive leader who identifies and exploits emerging market opportunities with proven products, Scott delivers aggressive business growth and organizational transformation utilizing creative solutions that overcome challenges in both consumer and business-to-business markets.
!!hns:g2_include_symposiumspeakerheader!!
Dennis Weissman Dennis Weissman Executive Editor, G2 Intelligence and Program Chair
One of the nation’s leading experts on the clinical diagnostic laboratory and pathology sectors, Dennis Weissman is President of Dennis Weissman & Associates, LLC and founder and Executive Editor of G2 Intelligence, an independent news and information company serving the health care industry.
Founded in 2004, Dennis Weissman & Associates, LLC provides public policy and strategic business intelligence and advice for the health care industry. Dennis is a well-known speaker before health care professional and industry trade groups nationwide. Prior to founding Washington G-2 Reports in 1979, he was Director of the Washington Office of the American Society for Medical Technology, and before that, worked as Special Assistant in the Office of the nation’s top health official in the U.S. Department of Health, Education, and Welfare.
He holds a bachelor’s degree in political science from the State University of New York at Buffalo and a master’s degree in higher education administration from Indiana University.

Platinum Sponsor:

corporate logo

Conference Wi-Fi compliments of:

Slone Logo

Gold Sponsors:

corporate logo corporate logo corporate logo corporate logo corporate logo corporate logo

Silver Sponsors:

corporate logo corporate logo corporate logo corporate logo corporate logo corporate logo

corporate logo corporate logo
corporate logo corporate logo corporate logo

Sponsors:

corporate logo
corporate logo
corporate logo
corporate logo
corporate logo